TherapeuticsMD (TXMD) Assets Average (2011 - 2026)

TherapeuticsMD's Assets Average history runs 15 years deep, the most recent figure standing at $37.6 million for Q1 2026.

• Quarterly Assets Average fell 2.36% year-over-year to $37.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.6 million (down 2.36% YoY) and the FY2025 annual result came in at $38.2 million, down 6.88% from the prior year.
• Assets Average was $37.6 million for Q1 2026 at TherapeuticsMD, down from $38.2 million in the prior quarter.
• Across five years, Assets Average topped out at $151.4 million in Q1 2022 and bottomed at $37.6 million in Q1 2026.
• A 5-year average of $66.4 million and a median of $42.7 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average plunged 62.81% — and 2026, when it declined 2.36%.
• TherapeuticsMD's Assets Average stood at $112.2 million in 2022, then sank by 58.19% to $46.9 million in 2023, then declined by 16.45% to $39.2 million in 2024, then dropped by 2.61% to $38.2 million in 2025, then retreated by 1.43% to $37.6 million in 2026.
• Business Quant data shows TXMD's Assets Average at $37.6 million in Q1 2026, $38.2 million in Q4 2025, and $38.6 million in Q3 2025.